Prevalence and characteristics of children with otitis media with effusion in Vietnam.

• Prevalence of childhood otitis media with effusion; 17% before pneumococcal vaccine. • Pneumococcus carriage and otitis media was associated among children under one. • Daycare attendance and rural residence were positively associated with otitis media. • Further studies after introducing pneumococcal vaccines are required. Otitis media with effusion (OME) commonly occurs and persists in young children. It can cause hearing impairment and damage to the tympanic membrane without treatment. We aimed to determine the prevalence and association of Streptococcus pneumoniae in the nasopharynx of healthy children before the introduction of a pneumococcal conjugate vaccine. In October 2016, nasopharyngeal swabs collection and otoscope examinations by an otolaryngologist were conducted in children aged less than 24 months in Nha Trang, Vietnam. OME was diagnosed as the presence of middle ear fluid using a digital otoscope equipped with a pneumatic otoscope. Quantitative PCR targeting pneumococci-specific lytA (the major autolysis gene) and bacterial culture were performed to detect S. pneumoniae. The point prevalence of OME in the study area was estimated. The association between OME and S. pneumoniae in the nasopharynx was evaluated using a multivariable logistic regression model. Among the 274 children who underwent bilateral ear examinations and nasopharyngeal swab collections, 47 had OME (17.2%, 95% confidence interval [CI] 12.9–22.1%) and 96 were colonized with S. pneumoniae (35.0%, 29.4–41.0%). OME and nasopharyngeal S. pneumoniae carriage were positively associated in children aged less than 12 months (adjusted odds ratio [aOR] 3.83, 1.40–10.51). Day-care attendance and living in a rural area were independently associated with OME (aOR 5.87, 2.31–14.91, and aOR 3.77, 1.58–8.99, respectively). The nasopharyngeal pneumococcal carriage was associated with OME among children aged <12 months. A further study after introducing a pneumococcal conjugate vaccine (PCV) is required to better understand the effect of PCV and S. pneumoniae carriage on OME in young children. [ABSTRACT FROM AUTHOR]